GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Clinical trial NCT00324831 · SUSPENDED
Trial details
- NCT number
- NCT00324831
- Sponsor
- Favrille
- Status
- SUSPENDED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.